| P2093 | author name string | Ralf G Thiele | |
| | Michael Barnes | |
| | John J Treanor | |
| | F Eun-Hyung Lee | |
| | Bo Zheng | |
| | Changyong Feng | |
| | Christopher T Ritchlin | |
| | Alexander F Rosenberg | |
| | Ignacio Sanz | |
| | James J Kobie | |
| | Chungwen Wei | |
| | Jennifer H Anolik | |
| | R John Looney | |
| | Allen P Anandarajah | |
| | Andreea Coca | |
| | Peter Bryk | |
| | Darren A Tabechian | |
| P2860 | cites work | Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers | Q71095987 |
| | Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab | Q79784933 |
| | Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion | Q81096856 |
| | Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory | Q83019433 |
| | Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity | Q84760318 |
| | Elucidation of seventeen human peripheral blood B-cell subsets and quantification of the tetanus response using a density-based method for the automated identification of cell populations in multidimensional flow cytometry data | Q24605194 |
| | Rapid cloning of high-affinity human monoclonal antibodies against influenza virus | Q24644672 |
| | Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks | Q28263815 |
| | Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune re | Q28594116 |
| | Signalling pathways of the TNF superfamily: a double-edged sword | Q29616428 |
| | Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection | Q30398435 |
| | Tumor necrosis factor alpha p55 receptor is important for development of memory responses to blood-stage malaria infection | Q33592023 |
| | The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination | Q33845366 |
| | Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization | Q34205800 |
| | Tumor necrosis factor blockade and the risk of viral infection | Q35161630 |
| | Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells | Q35609177 |
| | Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers | Q35636798 |
| | Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells | Q36401761 |
| | TNF inhibits production of stromal cell-derived factor 1 by bone stromal cells and increases osteoclast precursor mobilization from bone marrow to peripheral blood | Q36757010 |
| | Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. | Q37349889 |
| | The risk of infections with biologic therapies for rheumatoid arthritis | Q37360691 |
| | Plasma cell development and survival. | Q37781394 |
| | EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases | Q37816066 |
| | Measurement of Hemagglutination-Inhibiting Antibody to Influenza Virus in the 1976 Influenza Vaccine Program: Methods and Test Reproducibility | Q40859401 |
| | The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. | Q41101616 |
| | Expression of TNF-alpha by human plasma cells in chronic inflammation. | Q41107533 |
| | Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells | Q41698462 |
| | Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta | Q42096868 |
| | Methotrexate--how does it really work? | Q43144564 |
| | The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis | Q46107650 |
| | Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible | Q48004295 |
| | Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. | Q52950179 |
| | Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab. | Q53659586 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | R209 | |
| P577 | publication date | 2011-12-16 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor | |
| P478 | volume | 13 | |